The researchers from the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn analyzed the gene activity of cells found in the blood, which could eventually support conventional diagnostics and accelerate the beginning of therapy.
Enhancements include upgrading the platform’s sponsor-reviewer interaction, adding support for multi-omics, and offering a library of analytical, statistical, and machine learning applications that are both accessible to reviewers and sufficiently powerful for bioinformaticians.
John Halamka, M.D., will oversee Mayo Clinic Platform as it carries out initial projects focused on home healthcare scheduling, patient data uploading, and supplying patient-specific treatment information based on Mayo Clinic data.
The collaboration is intended to enhance Indivumed’s database by adding proteome-level data from thousands of samples using Biognosys’ proteomics technology, with the goal of enabling discoveries in cancer biology.
The array will be optimized to capture the unique variants found in South Asian genomes, leveraging the Applied Biosystems Axiom platform and MedGenome's proprietary database of 2.5 million variants that are unique to the South Asian population.
Researchers show how a technical bias in RNA-seq analysis—specifically a prevalent sample-specific length effect that leads to a strong association between gene length and fold-change estimates between samples—leads to recurrent false results.
While the tool is far from ready for common use, it suggests the potential to personalize depression prevention and identification of those who might be most vulnerable, or most resilient, to stress.
The collaboration will curate JAX’s Clinical Knowledgebase (CKB), a searchable database where subject matter experts store, sort, and interpret complex genomic and other data that can be used to improve patient outcomes.
The FH Foundation, a research and advocacy organization focused on familial hypercholesterolemia (FH), published a study today showing that a machine learning model it...
Novartis will establish an “AI innovation lab” designed to enable its research and commercial employees to use Microsoft’s artificial intelligence solutions across operations, with...